Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tracon Pharmaceuticals Inc
(NQ:
TCON
)
1.520
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tracon Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 25, 2023
Via
Benzinga
Nikola (NKLA) Stock Pops on Canadian Expansion News
April 25, 2023
Nikola (NKLA) stock is getting a boost on Tuesday following news that the EV company is expanding its business to Canada.
Via
InvestorPlace
What Is Going on With In8bio (INAB) Stock Today?
April 25, 2023
In8bio (INAB) stock is on the move Tuesday as investors react to a recent rally and additional news from the biotechnology company.
Via
InvestorPlace
Why Is TRACON Pharma (TCON) Stock Down 51% Today?
April 25, 2023
TRACON Pharmaceuticals (TCON) stock is falling on Tuesday morning following an update on a legal battle with I-Mab (IMAB).
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 25, 2023
Via
Benzinga
A Preview Of TRACON Pharmaceuticals's Earnings
March 07, 2023
Via
Benzinga
Why Aaron's Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
April 25, 2023
Gainers ZeroFox Holdings, Inc. (NASDAQ: ZFOX) gained 36.7% to $1.49 in pre-market trading after dropping around 17% on Monday. ZeroFox completed the acquisition of LookingGlass Cyber Solutions, Inc.
Via
Benzinga
TRACON Pharmaceuticals Announces Arbitration Award in Dispute with I-Mab
April 25, 2023
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 25, 2023
It's time for another dive into the biggest pre-market stock movers as we check out the latest news worth watching on Tuesday!
Via
InvestorPlace
Runway Growth Finance Corp. Provides First Quarter 2023 Portfolio Update
April 06, 2023
From
Runway Growth Finance Corp.
Via
GlobeNewswire
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update
March 08, 2023
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON to Report Fourth Quarter and Year-End 2022 Financial Results and Provide Corporate Update on March 8, 2023
February 28, 2023
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 8, 2023
March 08, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Via
Benzinga
Runway Growth Finance Corp. Provides Fourth Quarter 2022 Portfolio Update
January 10, 2023
From
Runway Growth Finance Corp.
Via
GlobeNewswire
TRACON Pharmaceuticals Announces up to $30M Non-Recourse Non-Dilutive Financing Related to Arbitration Award Decision Expected in Q1 2023
December 27, 2022
Initial $3.5M Funding Maintains Cash Runway of Mid-2023
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON Touts Encouraging Objective Response Rates For Mid-Stage Cancer Study
December 14, 2022
Via
Benzinga
TRACON Pharmaceuticals Announces Positive Results Based on Double-Digit Objective Response Rate in Each Cohort from the Ongoing ENVASARC Phase 2 Pivotal Trial
December 14, 2022
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
December 14, 2022
On Wednesday, 115 stocks hit new 52-week lows.
Via
Benzinga
TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 in Combination with Envafolimab and Doxorubicin in Front Line Sarcoma
November 21, 2022
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
November 07, 2022
The Dow Jones jumped by over 400 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around...
Via
Benzinga
Earnings Scheduled For November 14, 2022
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
TRACON to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 14, 2022
October 31, 2022
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
$1.9 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying
October 20, 2022
The Dow Jones dropped by around 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Week In Review: AIM Vaccine Stages $20 Million IPO On Hong Kong Exchange
October 08, 2022
Beijing AIM Vaccine conducted a very small IPO on the Hong Kong exchange, raising just $20 million, which netted the company only $10 million. Interest in the offering was low, with less than 1% of the...
Via
Talk Markets
TRACON Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
October 06, 2022
US gold futures traded slightly higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Runway Growth Finance Corp. Provides Third Quarter 2022 Portfolio Update
October 06, 2022
From
Runway Growth Finance Corp.
Via
GlobeNewswire
TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of 12 Week Safety Data from ENVASARC Phase 2 Pivotal Trial - Trial to Proceed as Planned
October 06, 2022
Review of Interim Efficacy Data by IDMC to Occur in Fourth Quarter
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks.
Via
InvestorPlace
$1.2 Million Bet On ChromaDex? Check Out These 4 Penny Stocks Insiders Are Buying
October 04, 2022
The Dow Jones jumped by more than 750 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.